Get the Stockscreener App
1.23
3.15%
-0.04
After Hours:
1.25
0.02
+1.63%
Talphera Inc stock is traded at $1.23, with a volume of 358.29K.
It is down -3.15% in the last 24 hours and up +44.71% over the past month.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
See More
Previous Close:
$1.27
Open:
$1.27
24h Volume:
358.29K
Relative Volume:
0.14
Market Cap:
$25.24M
Revenue:
$2.82M
Net Income/Loss:
$-14.20M
P/E Ratio:
-1.4471
EPS:
-0.85
Net Cash Flow:
$-15.13M
1W Performance:
+29.47%
1M Performance:
+44.71%
6M Performance:
+150.82%
1Y Performance:
+53.75%
1-Day Range:
$1.20
$1.3499
1-Week Range:
$0.966
$1.4501
52-Week Range:
$0.38
$1.4501
Talphera Inc Stock (TLPH) Company Profile
Compare TLPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
1.23 | 57.89M | 2.82M | -14.20M | -15.13M | -0.85 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-20-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-11-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Aug-05-19 | Resumed | Credit Suisse | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Outperform |
| Apr-24-19 | Resumed | B. Riley FBR | Buy |
| Feb-15-19 | Initiated | Credit Suisse | Outperform |
| Oct-23-18 | Initiated | B. Riley FBR | Buy |
| Oct-13-17 | Downgrade | Jefferies | Buy → Hold |
| Oct-13-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-14-17 | Resumed | Jefferies | Buy |
| Sep-15-16 | Reiterated | ROTH Capital | Buy |
| Aug-05-16 | Downgrade | Stifel | Buy → Hold |
| Oct-30-15 | Upgrade | Jefferies | Hold → Buy |
| Oct-05-15 | Reiterated | ROTH Capital | Buy |
| Sep-02-15 | Initiated | H.C. Wainwright | Buy |
| Jul-10-15 | Resumed | ROTH Capital | Buy |
| May-06-15 | Reiterated | Mizuho | Neutral |
| May-05-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-10-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-09-15 | Downgrade | Mizuho | Buy → Neutral |
View All
Talphera Inc Stock (TLPH) Latest News
Is Talphera Inc. (R5XA) stock a good hedge against inflationWeekly Trend Summary & Safe Capital Growth Plans - newser.com
Why Talphera Inc. is moving todayWeekly Earnings Recap & AI Based Buy/Sell Signal Reports - newser.com
What momentum shifts mean for Talphera Inc.2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
How sustainable is Talphera Inc. stock dividend payout2025 Market Trends & High Accuracy Buy Signal Tips - newser.com
Is Talphera Inc. a candidate for recovery playJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - newser.com
How Talphera Inc. (R5XA) stock compares with market leadersMarket Volume Summary & Free Verified High Yield Trade Plans - newser.com
Talphera (NASDAQ:TLPH) and Xeris Biopharma (NASDAQ:XERS) Head-To-Head Contrast - Defense World
Sector ETF performance correlation with Talphera Inc.Layoff News & Daily Growth Stock Investment Tips - newser.com
Can volume confirm reversal in Talphera Inc.2025 Market Overview & Low Risk Growth Stock Ideas - newser.com
Is this a good reentry point in Talphera Inc.Market Performance Report & AI Powered Market Entry Strategies - newser.com
Talphera Inc R5XA Stock Analysis and ForecastCapital Gains Strategies & Low Risk Wealth Building - earlytimes.in
What analysts say about Talphera Inc stockTrading Volume Surges & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Is Talphera Inc. stock supported by strong fundamentalsJobs Report & Verified Momentum Stock Ideas - newser.com
How strong dollar benefits Talphera Inc. (R5XA) stockJuly 2025 PreEarnings & Risk Controlled Daily Trade Plans - newser.com
Statistical indicators supporting Talphera Inc.’s strengthWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Using Bollinger Bands to evaluate Talphera Inc.Trade Volume Summary & High Win Rate Trade Alerts - newser.com
Talphera, Inc. (NASDAQ:TLPH) Short Interest Update - Defense World
Is Talphera Inc. stock poised for growth2025 Short Interest & Target Return Focused Stock Picks - newser.com
Why Talphera Inc. stock appeals to analystsShort Setup & Safe Entry Momentum Stock Tips - newser.com
How Talphera Inc. stock performs in rising dollar environmentWeekly Market Summary & Real-Time Price Movement Reports - newser.com
What the charts say about Talphera Inc. todayWeekly Earnings Recap & Real-Time Market Sentiment Alerts - newser.com
Can Talphera Inc. stock resist sector downturnsJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
Short interest data insights for Talphera Inc.Index Update & Consistent Growth Equity Picks - newser.com
9th Circ. Ruling May Help Pharma Cos. Avert Investor Claims - Law360
Talphera Inc Stock (TLPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Talphera Inc Stock (TLPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Dec 05 '24 |
Buy |
0.64 |
5,000 |
3,200 |
208,066 |
| ASADORIAN RAFFI | Chief Financial Officer |
Dec 02 '24 |
Sale |
0.77 |
155 |
119 |
37,578 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Nov 27 '24 |
Buy |
0.73 |
5,000 |
3,650 |
203,066 |
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):